A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Status:
Recruiting
Trial end date:
2024-08-09
Target enrollment:
Participant gender:
Summary
This study is to evaluate the preliminary efficacy and safety of chiauranib in combine with
capecitabine in advanced triple-negative breast cancer failed to prior anthracyclines and
taxanes therapy